Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
Ares Management Corporation · ARES · FY2024 Q4 · Calendar Q1 2025
Ares pairs strong fundraising with expansion and integration risks
The supplied analysis supports a constructive operating outlook for Ares, based on fundraising, platform diversification, dry powder, and expanding distribution. That view is conditional on effective acquisition integration, sustained fundraising, and improved transaction activity; the supplied record does not include a prior-quarter comparison or reported-versus-consensus results.
Reported Before market openNYSEFinancial Services
$37.97B market cap
70quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.35
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $1.23B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-2.9%
Event window
SPY move
+0.4%
Same window
Abnormal move
-3.3%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
-19.1%
Up to 20 sessions
ARESSPY benchmark
Ask FN2 about ARES FY2024 Q4
Transcript, numbers and history already loaded
What drove ARES's -2.9% move after FY2024 Q4 earnings?What changed in ARES's guidance and outlook in FY2024 Q4?Give me the bull and bear case for ARES after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The call analysis highlights leadership expansion, the pending GCP International acquisition, new real-asset and infrastructure vehicles, broader wealth and insurance distribution, and a higher dividend. It also adds detail on integration, G&A, deployment-ratio, tax, and competitive concerns.
Guidance delta
Management guidance sentiment was maintained; the supplied analysis does not identify a specific numerical guidance change.
Key takeaways
- Management’s analysis points to continued scale from fundraising, AUM growth, and diversified private-market platforms.
- The planned GCP International acquisition broadens real-asset capabilities, while new products and distribution channels support expansion.
- The main counterweights are integration execution, higher operating costs, transaction activity, and fundraising momentum.
Management priorities
- Close and integrate GCP International while developing new data-center, logistics, climate-infrastructure, and self-storage offerings.
- Expand wealth and insurance distribution through wirehouses, private banks, and related partnerships.
- Deploy dry powder across private credit and real assets while supporting continued dividend growth.
Follow ARES with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$115.62Previous close
$62Low
$158.37Average
$210High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 27, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 3, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 3, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 21, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| Raymond James | Strong Buy | Market Perform | Upgrade | Feb 9, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Feb 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Jan 13, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Nov 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 3, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Aug 6, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Jefferies | Hold | Hold | Maintain | May 9, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 13, 2023 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 25, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Nov 25, 2020 |
| Credit Suisse | Outperform | Neutral | Upgrade | Nov 25, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Nov 25, 2020 |
Named analyst price targets
Upside is calculated against the persisted previous close $115.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Daniel Welden | $136 | $116.57 | +17.6% | Oct 1, 2026 |
| Piper Sandler | Crispin Love | $150 | $121.48 | +29.7% | Sep 24, 2026 |
| RBC Capital | Bart Dziarski | $168 | $134.39 | +45.3% | Aug 3, 2026 |
| Deutsche Bank | Analyst unavailable | $144 | $135.01 | +24.5% | Aug 3, 2026 |
| Oppenheimer | Analyst unavailable | $151 | $133.2 | +30.6% | Aug 3, 2026 |
| BMO Capital | Brennan Hawken | $134 | $128.09 | +15.9% | Aug 3, 2026 |
| Morgan Stanley | Analyst unavailable | $160 | $121.14 | +38.4% | Jul 21, 2026 |
| BMO Capital | Analyst unavailable | $128 | $122.06 | +10.7% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $139 | $120.29 | +20.2% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $140 | $119.06 | +21.1% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $163 | $122.32 | +41.0% | Apr 21, 2026 |
| RBC Capital | Bart Dziarski | $173 | $115.94 | +49.6% | Feb 24, 2026 |
| UBS | Analyst unavailable | $148 | $128.16 | +28.0% | Feb 20, 2026 |
| RBC Capital | Analyst unavailable | $180 | $135.12 | +55.7% | Feb 9, 2026 |
| Oppenheimer | Analyst unavailable | $215 | $128.94 | +86.0% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $165 | $128.7 | +42.7% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $190 | $121.87 | +64.3% | Feb 6, 2026 |
| Deutsche Bank | Brian Bedell | $155 | $121.87 | +34.1% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $178 | $149.69 | +54.0% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $224 | $167.03 | +93.7% | Jan 20, 2026 |
| UBS | Analyst unavailable | $198 | $169.5 | +71.3% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $222 | $175.75 | +92.0% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $210 | $172.84 | +81.6% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $218 | $176.82 | +88.5% | Dec 12, 2025 |
| UBS | Michael Brown | $201 | $178.3 | +73.8% | Dec 11, 2025 |
| Oppenheimer | Chris Kotowski | $190 | $153.75 | +64.3% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $175 | $149.21 | +51.4% | Oct 21, 2025 |
| Oppenheimer | Analyst unavailable | $180 | $143.63 | +55.7% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $187 | $148.64 | +61.7% | Oct 8, 2025 |
| JMP Securities | Brian McKenna | $195 | $180.34 | +68.7% | Jul 14, 2025 |
| Wolfe Research | Steven Chubak | $193 | $159.63 | +66.9% | May 6, 2025 |
| Barclays | Benjamin Budish | $182 | $160.96 | +57.4% | May 6, 2025 |
| Wolfe Research | Steven Chubak | $218 | $180.87 | +88.5% | Jan 3, 2025 |
| RBC Capital | Kenneth Lee | $205 | $176.11 | +77.3% | Dec 10, 2024 |
| RBC Capital | Kenneth Lee | $170 | $157.81 | +47.0% | Oct 11, 2024 |
| Morgan Stanley | Michael Cyprys | $162 | $156.95 | +40.1% | Oct 10, 2024 |
| Barclays | Benjamin Budish | $174 | $160.39 | +50.5% | Oct 7, 2024 |
| CFRA | Kenneth Leon | $170 | $156.38 | +47.0% | Sep 23, 2024 |
| Wells Fargo | Michael Brown | $156 | $141.46 | +34.9% | Sep 11, 2024 |
| Redburn Partners | Nicholas Watts | $140 | $146.96 | +21.1% | Aug 27, 2024 |
| Barclays | Benjamin Budish | $155 | $139.26 | +34.1% | Aug 5, 2024 |
| CFRA | Kenneth Leon | $155 | $139.26 | +34.1% | Aug 2, 2024 |
| Barclays | Benjamin Budish | $151 | $134.78 | +30.6% | Jul 10, 2024 |
| Deutsche Bank | Brian Bedell | $132 | $137.49 | +14.2% | Jun 13, 2024 |
| Deutsche Bank | Brian Bedell | $176 | $146.7 | +52.2% | May 28, 2024 |
| UBS | Brent Dilts | $160 | $146.31 | +38.4% | May 22, 2024 |
| RBC Capital | Kenneth Lee | $150 | $136.17 | +29.7% | May 7, 2024 |
| Barclays | Benjamin Budish | $150 | $134.64 | +29.7% | May 3, 2024 |
| Barclays | Analyst unavailable | $87 | $75.1 | -24.8% | Jan 12, 2023 |
| Barclays | Analyst unavailable | $82 | $68.14 | -29.1% | Dec 19, 2022 |
| UBS | Analyst unavailable | $95 | $79.53 | -17.8% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $87 | $68.79 | -24.8% | Apr 29, 2022 |
| Morgan Stanley | Analyst unavailable | $90 | $81.94 | -22.2% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $92 | $79.71 | -20.4% | Apr 19, 2022 |
| Barclays | Jeremy Campbell | $62 | $53.55 | -46.4% | Apr 12, 2021 |
Track every rating change on ARES the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAres Management Corporation functions as an investment firm specializing in alternative assets, with operations spanning the United States, Europe, and Asia. Its Tradable Credit division oversees diverse investment vehicles, including pooled funds and separately managed accounts for institutional investors, alongside publicly traded products and sub-advised funds aimed at retail investors, all within the tradable and non-investment grade corporate credit markets. The Direct Lending segment delivers financial solutions to small and medium-sized businesses.…
Historical context
All ARES earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| GS-PA The Goldman Sachs Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +32.3% | — | Goldman’s financing and wealth engines strengthen as AI demand persists |
| GS-PD The Goldman Sachs Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +32.3% | — | Goldman Sachs posts record Q3 as financing and wealth remain strong |
| GS The Goldman Sachs Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +32.3% | -0.2% | Goldman Sachs posts record Q3 as financing and advisory stay strong |
| C Citigroup Inc. | FY2026 Q3 · Calendar Q4 2026 | +7.5% | -5.6% | Citi lifts ROTCE outlook after strong Q3, keeps investing |
| JPM-PK JPMorgan Chase & Co. | FY2026 Q3 · Calendar Q4 2026 | -6.1% | — | JPMorgan posts strong Q3 as deposits, markets and AWM support growth |
| JPM-PD JPMorgan Chase & Co. | FY2026 Q3 · Calendar Q4 2026 | -6.1% | — | JPMorgan Q3: Strong Results, Cautious on Rates and Credit |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the ARES recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-22T00:04:22.296664+00:00
- Polygon adjusted daily market bars · 2026-10-14T07:50:43.672177+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-14T07:50:43.669297+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-14. For educational purposes only; not investment advice.